Eszter Trojnár

869 total citations
16 papers, 647 citations indexed

About

Eszter Trojnár is a scholar working on Immunology, Epidemiology and Hepatology. According to data from OpenAlex, Eszter Trojnár has authored 16 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in Eszter Trojnár's work include Liver Disease Diagnosis and Treatment (6 papers), Liver Disease and Transplantation (4 papers) and Complement system in diseases (4 papers). Eszter Trojnár is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Liver Disease and Transplantation (4 papers) and Complement system in diseases (4 papers). Eszter Trojnár collaborates with scholars based in United States, Hungary and Finland. Eszter Trojnár's co-authors include Pál Pacher, Csaba Mátyás, György Haskó, Bin Gao, Yong He, Xiaolin Wang, Seonghwan Hwang, Lucas Liaudet, Dechun Feng and Suxian Zhao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Hepatology.

In The Last Decade

Eszter Trojnár

16 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eszter Trojnár United States	11	234	164	160	142	118	16	647
Kyle L. Poulsen United States	16	457 2.0×	257 1.6×	184 1.1×	169 1.2×	90 0.8×	29	878
Masato Tsuchiya Japan	16	224 1.0×	226 1.4×	163 1.0×	170 1.2×	119 1.0×	42	766
Karen M. Kassel United States	15	369 1.6×	268 1.6×	81 0.5×	142 1.0×	113 1.0×	20	800
Yoshinobu Saito Japan	14	409 1.7×	283 1.7×	81 0.5×	105 0.7×	91 0.8×	34	754
Karim Hamesch Germany	8	245 1.0×	171 1.0×	126 0.8×	228 1.6×	71 0.6×	26	661
S. Galastri Italy	13	426 1.8×	161 1.0×	102 0.6×	334 2.4×	150 1.3×	17	790
Hidenari Nagai Japan	14	203 0.9×	173 1.1×	69 0.4×	308 2.2×	83 0.7×	76	649
Yasushi Takii Japan	14	331 1.4×	123 0.8×	79 0.5×	287 2.0×	192 1.6×	18	691
Caryn L. Elsegood Australia	16	161 0.7×	227 1.4×	203 1.3×	140 1.0×	130 1.1×	30	692

Countries citing papers authored by Eszter Trojnár

Since Specialization

Citations

This map shows the geographic impact of Eszter Trojnár's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eszter Trojnár with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eszter Trojnár more than expected).

Fields of papers citing papers by Eszter Trojnár

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eszter Trojnár. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eszter Trojnár. The network helps show where Eszter Trojnár may publish in the future.

Co-authorship network of co-authors of Eszter Trojnár

This figure shows the co-authorship network connecting the top 25 collaborators of Eszter Trojnár. A scholar is included among the top collaborators of Eszter Trojnár based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eszter Trojnár. Eszter Trojnár is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wagner, Josephin, Partha Mukhopadhyay, Csaba Mátyás, et al.. (2024). PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injury. Brain Behavior and Immunity. 119. 494–506. 11 indexed citations

Mátyás, Csaba, Eszter Trojnár, Suxian Zhao, et al.. (2023). PCSK9, A Promising Novel Target for Age-Related Cardiovascular Dysfunction. JACC Basic to Translational Science. 8(10). 1334–1353. 21 indexed citations

Arif, Muhammad, Csaba Mátyás, Partha Mukhopadhyay, et al.. (2023). Data-driven transcriptomics analysis identifies PCSK9 as a novel key regulator in liver aging. GeroScience. 45(5). 3059–3077. 10 indexed citations

Karvaly, Gellért, István Karádi, István Vincze, et al.. (2021). A pharmacokinetics‐based approach to the monitoring of patient adherence to atorvastatin therapy. Pharmacology Research & Perspectives. 9(5). e00856–e00856. 3 indexed citations

Uzonyi, Barbara, Eszter Trojnár, Satu Hyvärinen, et al.. (2021). Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder. Frontiers in Immunology. 12. 660382–660382. 12 indexed citations

He, Yong, Robim M. Rodrigues, Xiaolin Wang, et al.. (2020). Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223–enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis. Journal of Clinical Investigation. 131(3). 135 indexed citations

Mátyás, Csaba, György Haskó, Lucas Liaudet, Eszter Trojnár, & Pál Pacher. (2020). Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. Nature Reviews Cardiology. 18(2). 117–135. 89 indexed citations

Lee, Ji Soo, Partha Mukhopadhyay, Csaba Mátyás, et al.. (2019). PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease. Scientific Reports. 9(1). 17167–17167. 59 indexed citations

Xiang, Xiaogang, Dechun Feng, Seonghwan Hwang, et al.. (2019). Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice. Journal of Hepatology. 72(4). 736–745. 131 indexed citations

10.

Trojnár, Eszter, Katalin Erdélyi, Csaba Mátyás, et al.. (2019). Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome. Free Radical Biology and Medicine. 152. 540–550. 27 indexed citations

11.

Trojnár, Eszter, Mihály Józsi, Marienn Réti, et al.. (2019). Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies. Frontiers in Immunology. 10. 240–240. 4 indexed citations

12.

Trojnár, Eszter, James F. Sinclair, Zhimei Liu, et al.. (2019). Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a In Vivo and In Vitro. Infection and Immunity. 87(4). 21 indexed citations

13.

Mátyás, Csaba, Katalin Erdélyi, Eszter Trojnár, et al.. (2019). Interplay of Liver–Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic Cardiomyopathy. Hepatology. 71(4). 1391–1407. 57 indexed citations

14.

Trojnár, Eszter, et al.. (2018). Role of complement in the pathogenesis of thrombotic microangiopathies. memo - Magazine of European Medical Oncology. 11(3). 227–234. 1 indexed citations

15.

Trojnár, Eszter, Mihály Józsi, Katalin Uray, et al.. (2017). Analysis of Linear Antibody Epitopes on Factor H and CFHR1 Using Sera of Patients with Autoimmune Atypical Hemolytic Uremic Syndrome. Frontiers in Immunology. 8. 302–302. 10 indexed citations

16.

Bhattacharjee, Arnab, Stefanie Reuter, Eszter Trojnár, et al.. (2015). The Major Autoantibody Epitope on Factor H in Atypical Hemolytic Uremic Syndrome Is Structurally Different from Its Homologous Site in Factor H-related Protein 1, Supporting a Novel Model for Induction of Autoimmunity in This Disease. Journal of Biological Chemistry. 290(15). 9500–9510. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact